ES2145746T3 - Analisis de deteccion de hepatitis c. - Google Patents

Analisis de deteccion de hepatitis c.

Info

Publication number
ES2145746T3
ES2145746T3 ES92920853T ES92920853T ES2145746T3 ES 2145746 T3 ES2145746 T3 ES 2145746T3 ES 92920853 T ES92920853 T ES 92920853T ES 92920853 T ES92920853 T ES 92920853T ES 2145746 T3 ES2145746 T3 ES 2145746T3
Authority
ES
Spain
Prior art keywords
assay
hepatitis
detection analysis
sample
hcv antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92920853T
Other languages
English (en)
Other versions
ES2145746T5 (es
Inventor
Richard R Lesniewski
Tat K Leung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25058660&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2145746(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2145746T3 publication Critical patent/ES2145746T3/es
Publication of ES2145746T5 publication Critical patent/ES2145746T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Steroid Compounds (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN ENSAYO PERFECCIONADO PARA DETECTAR LA PRESENCIA DE UN ANTICUERPO A UN ANTIGENO HCV EN UNA MUESTRA, MEDIANTE EL CONTACTO DE LA MUESTRA CON, AL MENOS, UN POLIPEPTIDO QUE CONTENGA, AL MENOS, UN "EPITOPE" DE UN ANTIGENO HCV. LOS FORMATOS DE ENSAYO PREFERENTES INCLUYEN UN ENSAYO CONFIRMATORIO, UN ENSAYO DE COMBINACION, UN ENSAYO CON BASE DE POLIPEPTIDO SINTETICO, UN ENSAYO INMUNOEXPLORACION Y UN ENSAYO DE COMPETICION.
ES92920853T 1991-09-16 1992-09-16 Analisis de deteccion de la hepatitis c. Expired - Lifetime ES2145746T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76029291A 1991-09-16 1991-09-16
US760292 1991-09-16

Publications (2)

Publication Number Publication Date
ES2145746T3 true ES2145746T3 (es) 2000-07-16
ES2145746T5 ES2145746T5 (es) 2005-04-16

Family

ID=25058660

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92920853T Expired - Lifetime ES2145746T5 (es) 1991-09-16 1992-09-16 Analisis de deteccion de la hepatitis c.

Country Status (9)

Country Link
EP (1) EP0642666B2 (es)
JP (1) JP3219409B2 (es)
AT (1) ATE191792T1 (es)
AU (1) AU2679492A (es)
CA (1) CA2119013A1 (es)
DE (1) DE69230917T3 (es)
ES (1) ES2145746T5 (es)
TW (1) TW222686B (es)
WO (1) WO1993006247A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232815T5 (es) 1993-05-10 2009-06-15 Novartis Vaccines And Diagnostics, Inc. Metodos de tipado del virus de la hepatitis c y reactivos para usar en los mismos.
PT992580E (pt) * 1993-11-04 2005-07-29 Innogenetics Nv Epitopos para celulas t humanas imunodominantes do virus da hepatite c
WO1996004385A2 (en) 1994-07-29 1996-02-15 Innogenetics N.V. Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
JP3665371B2 (ja) * 1994-08-31 2005-06-29 株式会社先端生命科学研究所 Ｃ型肝炎ウイルス感染又はグループ判定のためのエピトープキメラ抗原ペプチド、その製法、及びそれを使用する感染又はグループ判定法
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
JPH11507129A (ja) * 1995-06-07 1999-06-22 アボツト・ラボラトリーズ Ｃ型肝炎ウイルス第二エンベロープ糖タンパク質に対する抗体の検出法
JP3715027B2 (ja) * 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
JP2002171972A (ja) * 1996-10-14 2002-06-18 Chemo Sero Therapeut Res Inst 肝炎ウイルスエピトープ
AU752131C (en) * 1997-11-06 2003-12-04 Innogenetics N.V. Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
WO2000026673A1 (en) * 1998-11-03 2000-05-11 Abbott Laboratories Methods of detecting chronic infection caused by hcv
EP1195381A1 (de) 2000-09-28 2002-04-10 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
JP4975601B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
BR112012030808A2 (pt) * 2010-06-02 2016-11-01 Mp Biomedicals Asia Pacific Pte Ltd ensaio de vírus da hepatite c de multilinhagem rápido

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063810B1 (en) * 1981-04-29 1986-03-05 Ciba-Geigy Ag New devices and kits for immunological analysis
HU225068B1 (en) † 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
JP3156200B2 (ja) * 1989-09-15 2001-04-16 国立予防衛生研究所長 新規のｈｃｖ分離株
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay

Also Published As

Publication number Publication date
DE69230917T3 (de) 2005-04-07
JPH06510861A (ja) 1994-12-01
DE69230917D1 (de) 2000-05-18
JP3219409B2 (ja) 2001-10-15
TW222686B (es) 1994-04-21
CA2119013A1 (en) 1993-04-01
AU2679492A (en) 1993-04-27
EP0642666A4 (en) 1994-11-22
WO1993006247A1 (en) 1993-04-01
EP0642666B1 (en) 2000-04-12
ES2145746T5 (es) 2005-04-16
DE69230917T2 (de) 2000-11-16
ATE191792T1 (de) 2000-04-15
EP0642666A1 (en) 1995-03-15
EP0642666B2 (en) 2004-08-11

Similar Documents

Publication Publication Date Title
DE69022578D1 (de) Test für Hepatitis-C.
TW222686B (es)
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
FI913560A0 (fi) Syntetiska peptider, speciellt foer observation av hcv-anti-kroppar, hcv-infektionsdiagnos och dess foerhindrande sm vaccin.
ES2148225T3 (es) Reactivos y procedimientos que permiten la deteccion y la cuantificacion de la tiroxina en muestras de fluido.
ATE225512T1 (de) Abtrennungsverfahren
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DE69232902D1 (de) Trennung und Analyse
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
ES2156858T3 (es) Reactivo de diagnostico para hepatitis c.
KR930703613A (ko) 시료 희석물중 과산화물 디스뮤타제의 용도
EP0600000A4 (en) HEPATITIS C DETECTION TEST USING RECOMBINANT ANTIGENS OF THE NS5 REGION.
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
KR920018075A (ko) 비-a, 비-b형 간염 비루스에 대해 생성된 항체와 면역화학적으로 반응하는 펩티드
KR930007970A (ko) 비-에이 형 , 비-비형 펩티드
KR910001378A (ko) HIV p24 정량 패널
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin
DE60018785D1 (de) Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin
FI102217B1 (fi) Menetelmä Pseudomonas aeruginosa-serotyyppien toteamiseksi näytteestä in vitro monoklonaalisten vasta-aineiden avulla, menetelmässä käytettäviä monoklonaalisia vasta-aineita sekä menetelmässä käyttökelpoinen testipakkaus
BR8401257A (pt) Reagente sorologico caracterizado pela acao combinada de substancias inibidoras de fatores lectinosimilares ou anticorpos inespecificos e substancias detectoras de antigenos e anticorpos especificos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 642666

Country of ref document: ES